Seqirus.com

Seqirus.com has Server used 12.3.33.229 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2015-05-08 (6 years, 35 days) and hosted in United States, server ping response time 11 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Seqirus keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Seqirus address
2 Seqirus log in
3 Seqirus.de
4 Seqirus/afluria
5 Seqirus asx
6 Seqirus uk
7 Seqirus jobs
8 Seqirus phone
9 Seqirus salary

Hosting Provider

Website: Seqirus.com
Hostname: csl.com
Country:
Latitude: 37.750999450684
Longitude: -97.821998596191
Area Code: 0
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Mwmp.org (2 seconds ago)

   » Stitchfix.com (2 seconds ago)

   » Plussizewomenfashion.com (22 seconds ago)

   » Cfsna.net (6 seconds ago)

   » Thetrendspotter.net (15 seconds ago)

   » Seqirus.com (1 seconds ago)

   » Outfittrends.com (5 seconds ago)

   » Ivp.com (25 seconds ago)

   » Divinepizza.com (4 seconds ago)

   » Vietmobitv.com (11 seconds ago)

Results For Websites Listing

Found 45 Websites with content related to this domain, It is result after search with search engine

Seqirus Publishes New Real-World Evidence Supporting The

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 68

  • Seqirus is part of CSL Limited (ASX: CSL)
  • As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a

Seqirus Careers And Employment Indeed.com

Indeed.com   DA: 14 PA: 12 MOZ Rank: 27

  • Find out what works well at Seqirus from the people who know best
  • Get the inside scoop on jobs, salaries, top office locations, and CEO insights
  • Compare pay for popular roles and read about the team’s work-life balance
  • Uncover why Seqirus is the best company for you.

Seqirus Begins Shipping 2020/21 Influenza Vaccines To U.S

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 69

  • Seqirus is part of CSL Limited (ASX: CSL)
  • As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to …

Seqirus Announces U.S. FDA Approval Of Expanded Age

Bloomberg.com   DA: 17 PA: 50 MOZ Rank: 70

As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner …

Seqirus Announces U.S. FDA Approval Of Its First-Ever

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 72

  • Seqirus is part of CSL Limited (ASX: CSL), headquartered in Melbourne, Australia
  • The CSL Group of companies employs more than 22,000 people with operations in more than 60 countries. Seqirus

Working At Seqirus In Holly Springs, NC: Employee Reviews

Indeed.com   DA: 14 PA: 20 MOZ Rank: 39

  • Seqirus is a beautiful facility in Holly Springs, NC
  • There are so many opportunities for advancement! The company is thriving and continuing to rapidly grow!

Seqirus Salaries Glassdoor

Glassdoor.com   DA: 17 PA: 37 MOZ Rank: 60

A free inside look at Seqirus salary trends based on 162 salaries wages for 110 jobs at Seqirus. Salaries posted anonymously by Seqirus employees.

Afluria Quadrivalent, Afluria Quadrivalent Southern

Fda.gov   DA: 11 PA: 50 MOZ Rank: 68

For active immunization against influenza disease cause by influenza A subtype viruses and type B viruses contained in vaccine.

Seqirus Presents New Phase 3 Clinical Data Supporting Use

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 75

Seqirus Presents New Phase 3 Clinical Data Supporting Use of Cell-Based Seasonal Influenza Vaccine in Children Six Months Through <4 Years of Age Seqirus Presents New Phase 3 …

Seqirus Reviews Glassdoor

Glassdoor.com   DA: 17 PA: 37 MOZ Rank: 63

  • A free inside look at company reviews and salaries posted anonymously by employees.

Vaccine Maker Seqirus Plots $800M Investment Into Major

Fiercepharma.com   DA: 20 PA: 50 MOZ Rank: 80

  • As one of the largest flu vaccine makers in the world, Seqirus is working overtime to churn out doses amid a key influenza season

Seqirus Will Build World-class, Next-generation $800m

Miragenews.com   DA: 18 PA: 50 MOZ Rank: 79

  • Seqirus is a wholly owned subsidiary of CSL Limited, which will invest more than AUD$800 million in capital expenditure to construct the facility
  • The building is expected to be operational by mid-2026
  • Seqirus will also invest significant, ongoing capital over the coming years in the advanced-manufacturing biopharmaceutical facility.

Seqirus Begins Shipping 2020/21 Influenza Vaccines To U.S

Multivu.com   DA: 15 PA: 50 MOZ Rank: 77

  • Seqirus is part of CSL Limited (ASX: CSL)
  • As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness
  • With state-of-the-art production facilities in the U.S., the U.K
  • and Australia, and leading R&D

New Flu Vaccine From Holly Springs Gets FDA Green Light

Ncbiotech.org   DA: 17 PA: 50 MOZ Rank: 80

  • Seqirus, a subsidiary of Australian pharma giant CSL, has a production facility in Holly Springs
  • It has received the go-ahead from the U.S
  • Food and Drug Administration to produce and sell its Fluad Quadrivalent vaccine
  • The vaccine is specifically developed to protect adults 65 years and older against four strains of seasonal influenza.

Average Seqirus Salary PayScale

Payscale.com   DA: 16 PA: 36 MOZ Rank: 66

  • The average salary for Seqirus employees is $78,267 per year
  • Visit PayScale to research Seqirus salaries, bonuses, reviews, benefits, and more!

Sr. Director, Global Market Access Job In Summit, NJ At

Ziprecruiter.com   DA: 20 PA: 50 MOZ Rank: 85

Develop Seqirus Portfolio Global Market Access strategy to drive leadership in market development, shaping, and pricing execution: Provide leadership to Seqirus Vaccines business by communicating the current access and value requirements landscape, and by advocating for appropriate investment in evidence and market access programs.

Seqirus Injects $580m Into Australian Vaccine Plant

Bioprocessintl.com   DA: 18 PA: 50 MOZ Rank: 84

  • Seqirus injects $580m into Australian cell-based flu vaccine plant
  • by Dan Stanton Tuesday, November 17, 2020 11:48 am
  • The site in Melbourne will be the first cell-based manufacturing facility in the southern hemisphere to produce flu vaccines, along with Seqirus’ adjuvant MF59 and Australian antivenoms
  • Seqirus has been making seasonal flu

Seqirus Publishes New Real-World Evidence Supporting The

Biospace.com   DA: 16 PA: 50 MOZ Rank: 83

  • Seqirus is part of CSL Limited (ASX: CSL)
  • As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness.

An Efficacy, Immunogenicity And Safety Study Investigating

Clinicaltrials.gov   DA: 22 PA: 21 MOZ Rank: 61

Access: SEQIRUS considers requests from qualified scientific and medical researchers to disclose protocols, anonymized subject-level data and study-level data when there is medical, scientific and/or public health interest to ensure the safe use of a Seqirus product licensed on or after 1 January 2014 in the US and/or EU.

- McKesson Medical-Surgical

Mms.mckesson.com   DA: 16 PA: 44 MOZ Rank: 79

  • Medical professionals, medical facility employees 855.571.2100
  • Need help with SupplyManager? 800.422.0280
  • Accounts Receivable 800.453.5180

CSL's Seqirus Exports To Surge With New Vaccine Facility

Afr.com   DA: 11 PA: 50 MOZ Rank: 81

The offshore opportunities for CSL's flu vaccine subsidiary Seqirus are set to grow considerably thanks to the new $800 million manufacturing facility set to be completed in 2026.

Seqirus Receives FDA Approval For FLUAD® QUADRIVALENT

Biospace.com   DA: 16 PA: 50 MOZ Rank: 87

  • About Seqirus Seqirus is part of CSL Limited (ASX: CSL)
  • As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness.

This EU Flu Day, Seqirus Confirms Record Number Of

Bloomberg.com   DA: 17 PA: 50 MOZ Rank: 89

This EU Flu Day, Seqirus confirms record number of influenza vaccines delivered across Europe to meet increased demand October 14, 2020, 2:00 AM EDT SHARE THIS ARTICLE

Seqirus Joins Big Pharma Competitors In Quadrivalent Flu

Fiercepharma.com   DA: 20 PA: 50 MOZ Rank: 93

  • Seqirus president Gordon Naylor has pegged a switch to quadrivalent flu vaccines as one growth driver for the budding CSL unit

Seqirus Investing $140M In Holly Springs, North Carolina

Businessfacilities.com   DA: 22 PA: 50 MOZ Rank: 96

  • Seqirus is part of CSL Limited, headquartered in Melbourne, Australia
  • The CSL Group of companies employs more than 20,000 people with operations in more than 60 countries

Seqirus Confidential Protocol V118 18 6FEB17Version 5 Page

Clinicaltrials.gov   DA: 22 PA: 41 MOZ Rank: 88

  • Seqirus Confidential Protocol V118_18 6FEB17Version 5 Page 9of 121 PRO-01 TEMP 06 / Atlas No
  • 4/ Version Date: January 29, 2015 Name of Sponsor: Seqirus UK Ltd
  • Protocol number: V118_18 Generic name of study vaccine(s): MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine Tetanus Toxoid, Reduced

Seqirus Announces U.S. FDA Approval Of Expanded Age

Markets.businessinsider.com   DA: 27 PA: 50 MOZ Rank: 24

  • About Seqirus Seqirus is part of CSL Limited (ASX: CSL)
  • As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to …

IIS Data Code Sets CDC

Cdc.gov   DA: 11 PA: 37 MOZ Rank: 75

  • SEQ: 70461-0120-03: 70461-0120-04: SYRINGE, .5 mL: 90694: Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use: Southern Hemisphere 2020 Influenza Season; CVX Code CVX …

Seqirus USA Inc 25 Deforest Ave Summit, NJ Federal

Mapquest.com   DA: 16 PA: 40 MOZ Rank: 84

  • Seqirus USA Inc 25 Deforest Ave Summit NJ 07901
  • Menu & Reservations Make Reservations
  • Order Online Tickets Tickets See Availability Directions {{::location.tagLine.value.text}} Sponsored Topics
  • Help Get directions, reviews and information for Seqirus

Seqirus: Jobs LinkedIn

Linkedin.com   DA: 16 PA: 30 MOZ Rank: 75

Seqirus Pharmaceuticals Maidenhead, SL6 22,179 followers We are a global force in the fight against influenza, on the front line of protection since 1918.

Prevention Of Influenza During Mismatched Seasons In Older

Pubmed.ncbi.nlm.nih.gov   DA: 23 PA: 10 MOZ Rank: 63

  • 11 Seqirus USA, Summit, NJ, USA
  • PMID: 33577767 DOI: 10.1016/S1473-3099(20)30694-0 Abstract Background: The absolute degree of protection from influenza vaccines in older adults has not been studied since 2001
  • This study aimed to show the clinical efficacy of an MF59-adjuvanted quadrivalent influenza vaccine (aQIV) in adults 65 years or older

Seqirus Receives FDA Approval Of AFLURIA QUADRIVALENT

Businesswire.com   DA: 20 PA: 50 MOZ Rank: 19

  • Seqirus is part of CSL Limited (ASX:CSL), headquartered in Melbourne, Australia
  • The CSL Group of companies employs more than 20,000 people with operations in more than 60 countries.

Seqirus Ready To Reinforce Canada's Influenza Pandemic

Benzinga.com   DA: 16 PA: 50 MOZ Rank: 98

  • Seqirus Canada is an influenza pandemic vaccine partner to the Canadian Government through the Public Health Agency of Canada (PHAC)
  • The contract requires Seqirus to …

Seqirus Begins Shipment Of Seasonal Influenza Vaccines To

Multivu.com   DA: 15 PA: 50 MOZ Rank: 98

Seqirus is now shipping its complete portfolio of seasonal influenza vaccines to the US market in preparation for the upcoming influenza season Seqirus utilizes the latest technologies to offer the broadest portfolio of influenza vaccines in the US, including Fluad™ (Influenza Vaccine, Adjuvanted), Flucelvax Quadrivalent™ (Influenza Vaccine

Influenza Vaccines --United States Numbers CHIRP Codes

Chirp.in.gov   DA: 12 PA: 50 MOZ Rank: 96

  • Seqirus IIV4Afluria® 33332-0319-01
  • 0.5 mL syringe : 3 Years+ : 150 influenza, injectable, quadrivalent, preservative free Seqirus Pty Ltd
  • Afluria® IIV4 33332 -0219 -20 0.25 mL syringe 6 - 35 months 161 Influenza, injectable, quadrivalent, preservative free, pediatric

Recently Analyzed Sites

Mwmp.org (2 seconds ago)

Medicalhair4u.com (0 seconds ago)

Plussizewomenfashion.com (22 seconds ago)

Cfsna.net (6 seconds ago)

Thetrendspotter.net (15 seconds ago)

Maspex.com (0 seconds ago)

Outfittrends.com (5 seconds ago)

Ivp.com (25 seconds ago)

Divinepizza.com (4 seconds ago)

Ngemu.com (0 seconds ago)

Gitlab.com (3 seconds ago)

Myworldwar2.com (5 seconds ago)

Fsgw.org (3 seconds ago)

Cfs.cat (1 seconds ago)

Sixtyandme.com (3 seconds ago)

Vietchannels.com (6 seconds ago)

Stonemarkcm.com (10 seconds ago)

Zorqe.com (6 seconds ago)